Desjardins Global Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$829K Sell
2,877
-480
-14% -$131K 0.09% 193
2023
Q3
$902K Sell
3,357
-1,862
-36% -$465K 0.1% 183
2023
Q2
$1.16M Sell
5,219
-366
-7% -$84.9K 0.13% 167
2023
Q1
$1.35M Buy
5,585
+2,124
+61% +$521K 0.17% 119
2022
Q4
$908K Buy
3,461
+9
+0.3% +$2.41K 0.14% 144
2022
Q3
$778K Buy
3,452
+102
+3% +$24.7K 0.1% 181
2022
Q2
$815K Sell
3,350
-272
-8% -$66.7K 0.11% 172
2022
Q1
$875K Buy
3,622
+26
+0.7% +$5.97K 0.08% 200
2021
Q4
$808K Buy
+3,596
New +$759K 0.07% 222

Other funds holding AMGN

Desjardins Global Asset Management's AMGN Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its Amgen (AMGN) stake by 14% in Q4 2023, selling an estimated $131K and leaving 2,877 shares worth $829K. The position accounts for 0.09% of the portfolio, ranked #193.

Desjardins Global Asset Management first reported a position in AMGN in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.35M in Q1 2023. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Desjardins Global Asset Management held 2,877 shares of Amgen worth $829K as of Q4 2023.
  • Desjardins Global Asset Management sold 480 Amgen shares in Q4 2023, an estimated $131K.
  • Amgen made up 0.09% of Desjardins Global Asset Management's portfolio in Q4 2023, its #193 holding.
  • Desjardins Global Asset Management first reported a position in Amgen in Q4 2021 and has held it in 9 quarters since.
  • Desjardins Global Asset Management's Amgen position peaked at $1.35M in Q1 2023.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.